These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36948450)
1. Risk of lymphoid malignancies increased after Puumala virus infection in Finland, 2009-2019: A retrospective register-based cohort study. Kääriäinen S; Ollgren J; Dub T; Laine O; Sinisalo M; Hepojoki J; Strandin T; Kekäläinen E; Sane J; Lyytikäinen O Int J Infect Dis; 2023 Jun; 131():1-6. PubMed ID: 36948450 [TBL] [Abstract][Full Text] [Related]
2. Molecular and epidemiological characteristics of human Puumala and Dobrava-Belgrade hantavirus infections, Germany, 2001 to 2017. Faber M; Krüger DH; Auste B; Stark K; Hofmann J; Weiss S Euro Surveill; 2019 Aug; 24(32):. PubMed ID: 31411134 [TBL] [Abstract][Full Text] [Related]
3. Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor. Latronico F; Mäki S; Rissanen H; Ollgren J; Lyytikäinen O; Vapalahti O; Sane J Epidemiol Infect; 2018 Feb; 146(3):367-371. PubMed ID: 29310747 [TBL] [Abstract][Full Text] [Related]
4. Regional differences in long-term cycles and seasonality of Puumala virus infections, Finland, 1995-2014. Sane J; Ollgren J; Makary P; Vapalahti O; Kuusi M; Lyytikäinen O Epidemiol Infect; 2016 Oct; 144(13):2883-8. PubMed ID: 27113030 [TBL] [Abstract][Full Text] [Related]
5. Serological survey of Seewis virus antibodies in patients suspected for hantavirus infection in Finland; a cross-reaction between Puumala virus antiserum with Seewis virus N protein? Ling J; Vaheri A; Hepojoki S; Levanov L; Jääskeläinen A; Henttonen H; Vapalahti O; Sironen T; Hepojoki J J Gen Virol; 2015 Jul; 96(Pt 7):1664-75. PubMed ID: 25787939 [TBL] [Abstract][Full Text] [Related]
6. [Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia]. Cebalo L; Dusek T; Kuzman I; Markotić A Acta Med Croatica; 2003; 57(5):355-9. PubMed ID: 15011460 [TBL] [Abstract][Full Text] [Related]
13. Human Puumala hantavirus infection in northern Sweden; increased seroprevalence and association to risk and health factors. Bergstedt Oscarsson K; Brorstad A; Baudin M; Lindberg A; Forssén A; Evander M; Eriksson M; Ahlm C BMC Infect Dis; 2016 Oct; 16(1):566. PubMed ID: 27737653 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of levels of angiopoietin-1 and angiopoietin-2 is associated with severe courses of hantavirus infection. Nusshag C; Osberghaus A; Baumann A; Schnitzler P; Zeier M; Krautkrämer E J Clin Virol; 2017 Sep; 94():33-36. PubMed ID: 28734140 [TBL] [Abstract][Full Text] [Related]
15. Concomitant influence of helminth infection and landscape on the distribution of Puumala hantavirus in its reservoir, Myodes glareolus. Salvador AR; Guivier E; Xuéreb A; Chaval Y; Cadet P; Poulle ML; Sironen T; Voutilainen L; Henttonen H; Cosson JF; Charbonnel N BMC Microbiol; 2011 Feb; 11(1):30. PubMed ID: 21303497 [TBL] [Abstract][Full Text] [Related]